|
Biotechnology is an especially risky business. In this section, experts provide some helpful advice on avoiding the icebergs that could potentially sink your business. Read on to find out why you should be thinking about ways in which you can manage external and internal risk more effectively.
Managing conflicts of interest: a survival guide for biotechs
December 2006
Conflicts of interest in research can affect a company's ability to move a product through the approval process or attract investment. Avoid the pitfalls by taking pro-active steps to manage these risks.
Virtual reality: the promise and pitfalls of going virtual
September 2005
Because of their scale and cost advantages, virtual biotechs are attracting growing interest again. In theory, any element in the innovation chain of a biotech or medical device firm can be outsourced. In practice, the virtual model represents challenges to both investors and management.
Riding the risk cycle
July 2004
For startups, early identification and planning for potential risks can mean the difference between success and failure.
A counselor's dose of preventive medicine
June 2002
When it comes to dealing with legal issues, prevention is better
than cure, say David Redlick and Virginia Kapner.
Monopoly money
June 2001
Strategies used by the pharmaceutical industry to alleviate the pain of patent expiration provide some valuable lessons for the biotechnology sector. . .and also some cautionary tales.
 more articles
|
